These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 38318835)

  • 21. Targeting FGFR1 by β,β-dimethylacrylalkannin suppresses the proliferation of colorectal cancer in cellular and xenograft models.
    Zhao R; Yin F; Fredimoses M; Zhao J; Fu X; Xu B; Liang M; Chen H; Liu K; Lei M; Laster KV; Li Z; Kundu JK; Dong Z; Lee MH
    Phytomedicine; 2024 Jul; 129():155612. PubMed ID: 38669968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In
    Li H; Sun X; Yu F; Xu L; Miu J; Xiao P
    Nutrients; 2018 May; 10(5):. PubMed ID: 29747475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic Potential of Polyphenols and their Nanoformulations in the Treatment of Colorectal Cancer.
    Khan SH; Alhumaydhi FA; Khan MA; Younus H
    Anticancer Agents Med Chem; 2021 Oct; 21(16):2117-2129. PubMed ID: 33390126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer.
    Mokgautsi N; Kuo YC; Chen CH; Huang YJ; Wu ATH; Huang HS
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An in silico molecular docking and simulation study to identify potential anticancer phytochemicals targeting the RAS signaling pathway.
    Azmal M; Paul JK; Prima FS; Talukder OF; Ghosh A
    PLoS One; 2024; 19(9):e0310637. PubMed ID: 39298437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ginkgo biloba leaf extract induces DNA damage by inhibiting topoisomerase II activity in human hepatic cells.
    Zhang Z; Chen S; Mei H; Xuan J; Guo X; Couch L; Dobrovolsky VN; Guo L; Mei N
    Sci Rep; 2015 Sep; 5():14633. PubMed ID: 26419945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioinformatic analysis of the molecular targets of curcumin in colorectal cancer.
    Mahmoudi A; Jamialahmadi T; Kesharwani P; Sahebkar A
    Pathol Res Pract; 2024 Oct; 262():155533. PubMed ID: 39173464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the mechanism of Ginkgo biloba L. leaves in the treatment of vascular dementia based on network pharmacology, molecular docking, and molecular dynamics simulation.
    Pan J; Tang J; Gai J; Jin Y; Tang B; Fan X
    Medicine (Baltimore); 2023 May; 102(21):e33877. PubMed ID: 37233418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Research on bitter taste and efficacy of Ginkgo biloba extract based on UPLC-Q-TOF-MS~E integrated with molecular docking].
    Ge GB; Wu XY; Wang YJ; Hu JL; Tang B; Wu F
    Zhongguo Zhong Yao Za Zhi; 2024 Jul; 49(14):3784-3795. PubMed ID: 39099352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway.
    Lin W; Zheng L; Zhuang Q; Zhao J; Cao Z; Zeng J; Lin S; Xu W; Peng J
    BMC Complement Altern Med; 2013 Jun; 13():144. PubMed ID: 23800091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.
    Chu YC; Tsai TY; Yadav VK; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen MY
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uncovering the anti-obesity constituents in Ginkgo biloba extract and deciphering their synergistic effects.
    Zhang M; Hou XD; Liu W; Wang L; Jiang MF; Hou J; Tang H; Ge GB
    Fitoterapia; 2023 Dec; 171():105669. PubMed ID: 37683877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.
    Sloley BD; Urichuk LJ; Morley P; Durkin J; Shan JJ; Pang PK; Coutts RT
    J Pharm Pharmacol; 2000 Apr; 52(4):451-9. PubMed ID: 10813558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A sensitive and selective multiple reaction monitoring mass spectrometry method for simultaneous quantification of flavonol glycoside, terpene lactones, and biflavonoids in Ginkgo biloba leaves.
    Wang LT; Fan XH; Jian Y; Dong MZ; Yang Q; Meng D; Fu YJ
    J Pharm Biomed Anal; 2019 Jun; 170():335-340. PubMed ID: 30986686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of Ginkgo biloba extracts, Ginkgo biloba extract phospholipid complexes and Ginkgo biloba extract solid dispersions in rats.
    Chen ZP; Sun J; Chen HX; Xiao YY; Liu D; Chen J; Cai H; Cai BC
    Fitoterapia; 2010 Dec; 81(8):1045-52. PubMed ID: 20603197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of naturally occurring inhibitors against SARS-CoV-2 3CL
    Xiong Y; Zhu GH; Wang HN; Hu Q; Chen LL; Guan XQ; Li HL; Chen HZ; Tang H; Ge GB
    Fitoterapia; 2021 Jul; 152():104909. PubMed ID: 33894315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic and cerebral exposure to and pharmacokinetics of flavonols and terpene lactones after dosing standardized Ginkgo biloba leaf extracts to rats via different routes of administration.
    Chen F; Li L; Xu F; Sun Y; Du F; Ma X; Zhong C; Li X; Wang F; Zhang N; Li C
    Br J Pharmacol; 2013 Sep; 170(2):440-57. PubMed ID: 23808355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic lipase inhibition activity of trilactone terpenes of Ginkgo biloba.
    Bustanji Y; Al-Masri IM; Mohammad M; Hudaib M; Tawaha K; Tarazi H; Alkhatib HS
    J Enzyme Inhib Med Chem; 2011 Aug; 26(4):453-9. PubMed ID: 21028941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
    Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
    Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CB1 as a novel target for Ginkgo biloba's terpene trilactone for controlling chemotherapy-induced peripheral neuropathy (CIPN).
    Samandar F; Tehranizadeh ZA; Saberi MR; Chamani J
    J Mol Model; 2022 Aug; 28(9):283. PubMed ID: 36044079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.